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Abstract
Background: A variety of statistical methods have been suggested to assess the degree and/or the
location of spatial clustering of disease cases. However, there is relatively little in the literature
devoted to comparison and critique of different methods. Most of the available comparative studies
rely on simulated data rather than real data sets.
Methods: We have chosen three methods currently used for examining spatial disease patterns:
the M-statistic of Bonetti and Pagano; the Generalized Additive Model (GAM) method as applied
by Webster; and Kulldorff's spatial scan statistic. We apply these statistics to analyze breast cancer
data from the Upper Cape Cancer Incidence Study using three different latency assumptions.
Results: The three different latency assumptions produced three different spatial patterns of cases
and controls. For 20 year latency, all three methods generally concur. However, for 15 year latency
and no latency assumptions, the methods produce different results when testing for global
clustering.
Conclusion: The comparative analyses of real data sets by different statistical methods provides
insight into directions for further research. We suggest a research program designed around
examining real data sets to guide focused investigation of relevant features using simulated data, for
the purpose of understanding how to interpret statistical methods applied to epidemiological data
with a spatial component.
Background
Unusual geographical patterns of disease may give rise to
public concern and explanations are frequently sought.
Attention is often directed toward potential environmen-
tal and other factors associated with the disease in ques-
tion. These investigations often have high costs in time
and money, and thus it is important to verify objectively
that the distribution of cases is indeed "unusual". A
number of statistical methods have been suggested to
assess the degree and/or the location of spatial clustering
of disease cases. A good overview of the general statistical
problems of clustering in the area of public health is
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contained in [1]. For a review with somewhat more depth
but narrower scope see [2].
Despite the variety of available statistics, and the impor-
tance of understanding the methodology itself, there is
relatively little in the literature devoted to comparison
and critique of different methods. Most of the available
comparative studies rely on simulated data ([3,4] among
others) rather than real data sets. Notable exceptions
include the leukemia data from upstate New York, which
have been extensively analyzed with a variety of methods
(see for example [5]). The advantages of using simulated
data are clear, namely spatial patterns can be specified in
advance and power to detect patterns under specified con-
ditions can be considered. However, the complexity and
subtleties of real data sets are frequently beyond our abil-
ities to simulate, and the potentially large number of
parameters involved in such simulations make systematic
investigation of particular elements a daunting task.
In this paper we compare analytic methods using breast
cancer data from the Upper Cape Cod area of Massachu-
setts. Geographically, the Upper Cape has interesting fea-
tures that would be difficult to simulate otherwise. Its
shape is roughly rectangular, but with uneven edges. Pop-
ulation density is highly heterogeneous, including a large
non-residential "hole" in the southwest quadrant (Otis
Air Force Base). These geographic features have the poten-
tial to affect various spatial methods in different ways and
to different extents, making these data rich and complex
in a way that simulated data often are not. We chose to
compare three methods currently used for examining spa-
tial disease patterns; one is a global test for clustering, one
is a local test for clustering, and one combines a global
deviance statistic with locally estimated odds ratios. All
three methods are relatively simple to implement and
none require commercial software. However, only the
scan statistic has been implemented in stand-alone
software.
We do not attempt to provide a comprehensive compari-
son of all available methods or to provide a complete
analysis of the breast cancer data, and the reader should
not interpret the results of our investigation in the context
of breast cancer clusters in the Upper Cape Cod region. In
contrast to the many published reports on the New York
leukemia data, our purpose here is not to infer specific dif-
ferences between cases and controls in the breast cancer
data. Instead we aim to achieve a better understanding of
the analytic properties of the methods we have selected,
features of the data that may be problematic for each, and
which may be most appropriate for particular situations.
It is worth noting that the three methods are not directly
comparable, in the sense that one is essentially global (the
M-statistic); one is local (the scan statistic); and one calcu-
lates local odds ratios along with a global deviance statis-
tic (Webster's Generalized Additive Model (GAM)). Thus
there is no reason to expect that the results of hypothesis
testing using these very different methods should agree.
We argue that instances where the outcome of hypothesis
tests using each of these three methods are discordant may
reveal important aspects of the data that could not be per-
ceived by using any one method exclusively. In this sense,
these methods provide complementary views of the data.
The information contained in each approach should be
considered as part of a complete and thorough investiga-
tion of spatial patterns of disease.
Data
Data are from two population-based case-control studies
of breast cancer on Upper Cape Cod, Massachusetts [6-8].
The Massachusetts Cancer Registry was used to identify
incident breast cancer cases diagnosed from 1983–1993.
Controls were chosen to represent the underlying popula-
tion that gave rise to cases. Participants were restricted to
permanent residents of the upper Cape region with com-
plete residential histories. The case and control popula-
tions were frequency matched on age and vital status.
Cases and controls were geocoded and locations entered
into a Geographic Information System (GIS). For those
subjects that moved during the study period, multiple res-
idential locations were included in all analyses as
appropriate.
Three latency assumptions were used in this paper. The
zero latency analysis included all eligible residences i.e.
exposures occurring up to diagnosis were assumed to con-
tribute to the risk of disease. Thus all of the enrolled breast
cancer cases (n = 200, representing 321 distinct residential
locations) and matched controls (n = 471, representing
756 residential locations) are included in the zero latency
analyses.
However, cancers initiated by exposures to environmental
carcinogens may take much longer to develop. We there-
fore performed a 15 year and 20 year latency analysis by
restricting inclusion to the residences occupied by partici-
pants at least 15 (or 20) years prior to the diagnosis (or
index year, for controls). The 15 year latency analyses
include 107 cases (170 locations) and 193 controls (389
locations), while the 20 year latency analyses include 248
cases (391 locations) and 341 controls (509 locations).
The 20 year latency analysis includes subjects from a fol-
low-up study, thus numbers of cases and controls are
higher than would otherwise be expected due to the more
restrictive latency assumption.
The latency assumptions thus produce three spatial pat-
terns, giving case and control residences zero, 15, or 20Environmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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years prior to diagnosis. These data are described fully,
including methodology for selection of cases and con-
trols, demographics, and other features of the study pop-
ulation, in the final report of the full study as well as
follow-up papers on the breast cancer data; see [7,8] for
further details. For illustration, the spatial distributions of
breast cancer cases and controls (with no latency assump-
tion) are shown in Figure 1.
Methods
The three statistical methods described here are: Bonetti
and Pagano's M-statistic, based on the interpoint distance
distribution [5]; Webster's GAM approach, which uses
smoothing techniques [9]; and Kulldorff's spatial scan sta-
tistic [10]. The M-statistic is a global unfocused test, mean-
ing it is only concerned with departures of the spatial
distribution of cases from the distribution of controls,
without determining the location of any (possibly multi-
ple) clusters or other differences. The GAM method maps
disease odds ratios, provides a global test for deviation
from a flat map, and identifies locations with significantly
increased or decreased risk (here GAM is the conventional
designation for Generalized Additive Model, not the Geo-
graphic Analysis Machine of Openshaw [11], also used in
cluster investigations). It incorporates a smoothing func-
tion for location into a conventional logistic regression
which accounts for effects of covariates. Kulldorff's scan
statistic, the most widely used method for cluster investi-
gations, scans the entire study region for local excesses
and/or reductions of risk. Current implementations of the
binary (Bernoulli model) version of the scan statistic
allow adjustment for categorical covariates only, and the
M-statistic as implemented does not adjust for covariates
at all (although allowing for categorical covariates via
stratification would seem to be a straightforward exten-
sion of the existing method). For simplicity we have cho-
sen to apply all three methods to crude data only, thus
avoiding the need to consider the differences in covariate
adjustment across the three methods.
M-statistic
Bonetti-Pagano's M-statistic [5] is a non-parametric gen-
eral test for clustering. It operates by representing and
comparing the spatial distributions of two populations
(here cases and controls) via the interpoint distance distri-
bution. From any collection of n locations, we can calcu-
late the roughly n2/2 interpoint distances between
locations and consider the distribution of these distances.
Typically, a resampling procedure on the entire study pop-
ulation is used to generate a baseline (or null) distribu-
tion. Both the null distribution (estimated via
resampling) and the observed distribution (calculated
from the interpoint distances between cases) are binned
into histograms, each of which can be represented as a
vector. The test statistic is then a Malhalanobis-like dis-
tance between the two vectors, weighted by an estimate of
the covariance between histogram bins.
More formally, repeated resampling from the entire study
population (cases and controls) is used to estimate the
distribution of distances under the null hypothesis that
both populations are sampled from the same spatial dis-
tribution. Binning these distances and taking the mean
over all iterations gives expected counts for each bin of the
histogram. Experience with this method suggests that the
optimal number of bins grows roughly on the order of
 where n is the number of cases being assessed (see
also [12]). Denote by e the vector of expected values in
each bin, expressed as a proportion of the total number of
distances. Repeated resampling also allows us to estimate
the covariance of e, which we will denote by S, a k × k
square matrix.
The interpoint distances for the disease cases are calcu-
lated, binned, and written as a k-dimensional vector o, the
observed bin values (expressed as proportions). Then the
M-statistic is:
M = (o - e)'S-(o - e)
Breast cancer cases and controls Figure 1
Breast cancer cases and controls. Distribution of breast 
cancer cases (in red) and controls (in blue). Each point repre-
sents the residence of one participant. Locations in this map 
have been geographically altered to preserve confidentiality. 
Actual residences were used in the analysis.
nEnvironmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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where S- is the Moore-Penrose generalized inverse of the
sample covariance matrix S. Thus we calculate the differ-
ence between the expected (under the null hypothesis of
no clustering) bin proportions and the observed bin pro-
portions of the disease cases, inversely weighted by the
covariance estimator. As S-  is a positive semi-definite
matrix, M ≥ 0.
The asymptotic distribution of M is found in [5]. In prac-
tice we can use the resampling procedure to calculate the
distribution of M empirically under the null hypothesis.
Comparing the calculated value of the test statistic to the
null distribution gives a p-value that can be interpreted as
the probability that the spatial distribution of the disease
cases differs from the entire study population by chance
alone.
GAM smoothing
Webster et al. [9,13] have used a procedure based on
smoothing and generalized additive models (GAMs) to
map disease and detect clusters (see [14] for related work).
The generalized additive model predicts the log odds of
disease (logarithm of the ratio of cases to controls) as a
linear function of some covariates and a smooth function
of spatial coordinates.
Specifically, the model specifies that for an individual
with covariates zi and spatial location (xi, yi), the probabil-
ity pi of disease is given by:
logit(pi) = S(xi, yi) + βzi
where β denotes the vector of linear regression coefficients
for the covariates. S(x, y) is a bivariate smooth function.
Webster et al. use a loess (locally-weighted regression
smoother) because it is adaptive to changes in data den-
sity typically found in population maps. Around each
point in the study area, a variable sized window is con-
structed based on a predetermined number of nearest
neighbors; within this window, the data contribute to S(x,
y) according to a tricube weighting function. Details are
covered thoroughly in [15]. The window size (span) will
affect both the bias and the variance (i.e. the amount of
smoothing). Reducing the span reduces the bias but also
increases the variance (reducing smoothness). Various cri-
teria have been developed to balance these two properties
of the smoother. Webster et al. use the Akaike Information
Criterion (AIC), which averages the deviance but penal-
izes the number of degrees of freedom. Minimizing the
AIC estimates an "optimal" balance of bias and variance
[15] in a computationally feasible manner. The global sta-
tistic tests the null hypothesis of a flat map using the devi-
ance of the model with and without the smoothing term.
Among the available global test statistics, here we have
used the deviance statistic [9]. The distribution of the sta-
tistic is estimated using permutation testing, with the case-
control status permuted repeatedly. A pointwise test is
then used to locate areas with significantly increased or
decreased log odds relative to the map as a whole (the
overall case-control ratio for crude analyses). The permu-
tations also generate a distribution of the log odds at each
location under the null hypothesis. The local p-value is
determined by comparing the observed log odds with the
null distribution.
After all statistical tests are performed, the log odds are
converted to odds ratios using the entire study population
as a reference. The odds ratios are mapped and significant
"hot" and "cold" spots are delineated by drawing the .025
and .975 quantiles of the pointwise p-value surface. This
graphical display is a natural part of the statistic and offers
a rapid interpretation of the results of the calculations.
The entire procedure can be run with existing software,
e.g. S-Plus for the GAM and ArcView for mapping.
We note that care should be taken when interpreting the
map of local p-values, because there is no adjustment for
multiple testing. Thus under the null hypothesis of iden-
tical spatial distributions of cases and controls, we can
expect in general that statistically significant local p-values
will occur at a higher rate than the Type I error rate speci-
fied by the nominal alpha level. In other words, the local
p-values are not to be used for hypothesis testing since we
do not have adequate control of the Type I error rate. The
local p-values do provide information about the measure
of effect (in this case the local odds ratio), but inference
based on these local p-values alone should be avoided.
Scan statistic
Kulldorff's scan statistic [10] has become the most widely
used test for clustering in recent years, both because of its
efficacy in detecting single hot (or cold) spots as well as
the availability of the free software package SaTScan [16]
for implementing the test. The basic idea of the scan sta-
tistic is to allow circular windows of various sizes to range
across the study region. At each location, the rate of dis-
ease inside the window is compared to that outside the
window. A hot (respectively cold) spot is characterized by
a higher (lower) localized rate of disease.
In a case-control setting, the scan statistic is a likelihood
ratio test statistic under a Bernoulli probability model. For
a given zone (circular window) Z let pZ, qZ denote the
probability of a data point being a case inside or outside
the circle, respectively. The likelihood function under this
Bernoulli model can be expressed in a straightforward
fashion in terms of p, q, and the number of cases and con-
trols inside and outside Z. We can then calculate:Environmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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Let   denote the zone for which LZ achieves its maxi-
mum. This is called the most likely cluster, and we can cal-
culate a test statistic via a likelihood ratio test. Let L0 = supp
= q L(Z, pZ, qZ) be the likelihood under the null hypothesis
(no clustering) and use
as the statistic of interest. The most likely cold spot is cal-
culated similarly.
As with the other methods, inference is based on permu-
tation of the case-control status. Under repeated permuta-
tions, the distribution of λ under the null hypothesis is
generated, and we compare the observed value of λ to this
distribution to yield a p-value. As noted above, SaTScan
provides a relative risk for the most likely hot/cold spot,
here an odds ratio inside the circle divided by an odds
ratio outside the circle (hence not exactly comparable to
the odds ratio computed by the GAM method).
For this study, we used the most recent version of the pub-
licly available software [16] for analyzing binary (case-
control) data, searching for either hot or cold spots.
Results
The three statistics in question were calculated for the
breast cancer data with each of three latency periods. The
results, showing global p-values for the M-statistic and the
GAM method, and local p-value (for the identified "most
likely cluster") for the scan statistic, are summarized in
Table 1.
The three methods in general are not concordant when
considered in a hypothesis testing context. However, all
three methods are at least suggestive of significantly differ-
ent spatial patterns for cases and controls when applied to
the 20 year latency data set. The scan statistic result, while
not significant at the customary 0.05 level, is nonetheless
indicative of an excess of cases in the calculated most
likely cluster, and contributes evidence towards a differ-
ence between cases and controls when considered in the
context of the results of the other two statistics. The
smoothed map using the GAM method (Figure 2) shows
one hot and one cold spot, a situation in which all three
statistics are expected to maintain some reasonable sensi-
tivity. The corresponding "most likely cluster" produced
by the scan statistic is also shown (Figure 3). When
applied to the breast cancer data set with 15 year latency,
both the M-statistic and the GAM indicate differences in
the spatial distribution of cases and controls that are very
unlikely to be explained by chance. The scan statistic,
however, suggests that considered locally, random varia-
tion remains a plausible explanation. Examination of the
smoothed map (Figure 4) shows two distinct and promi-
nent hot spots in the data, and one cold spot. The pres-
ence of multiple clusters in the data may partially explain
the divergent results. The associated scan statistic output is
also shown (Figure 5).
When no latency is considered for breast cancer, the M-
statistic is no longer statistically significant, making the
GAM the only method that offers strong evidence against
chance alone explaining the spatial patterns in the data.
Figures 6 and 7 show the smoothed map for this data set
as produced by the GAM and the cluster identified by the
scan statistic, respectively. The GAM map shows a broad,
diffuse area of increased risk (odds ratios (ORs) roughly
2.0) along the coast and periphery in the northern Cape
Cod area. Kulldorff's likelihood-based method identifies
the same area and roughly the same relative risk (RR), but
the local excess of cases is not statistically significant. Both
methods are detecting a single hot spot, but it is elongated
instead of the optimal (circular) configuration for Kull-
dorff's method. The M-statistic provides no evidence of
global differences at the significance level of 0.05, perhaps
due to the diffuse nature of the apparent hot spot. Thus
the evidence for clustering in this data set is mixed.
Discussion
The discussion of results presented here should not be
construed as epidemiologic findings, but rather the out-
put of three statistical methods as applied to real data. The
maps produced are for illustration purposes only, and
should not be interpreted epidemiologically (one reason
being that we have not controlled for covariates).
We remark that the common use of the word "cluster" to
describe a disease hot spot represents only one kind of
departure of spatial difference between cases and controls.
The scan statistic alone restricts itself to this particular











Table 1: p-values associated with cluster statistics. Results (p-
values) of analysis using the scan statistic, the M-statistic, and the 
GAM method with deviance statistic.
Breast cancer
20 yr lat 15 yr lat No lat
scan stat 0.068 0.241 0.209
M-stat 0.015 0.008 0.539
GAM 0.003 0.006 0.046Environmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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kind of spatial difference and further places emphasis on
the single most likely circular hot or cold spot. We have
chosen to adopt here the broader but more flexible objec-
tive of detecting any difference in the spatial distribution
of cases compared to the controls. The problem of locat-
ing and quantifying local excesses or deficits is clearly
important, and both the scan statistic and the GAM
address this problem directly. The M-statistic does not,
although extensions of distance-based methods to the
problem of cluster location are currently being developed
[17].
We have presented applications of three well-developed
and theoretically-grounded methods to detect spatial dif-
ferences in the distribution of cases and controls in a real
data set. The different patterns seen in this data set, com-
prising breast cancer with different latency considerations,
affect the outcomes of these methods. We have identified
at least three features that plausibly are involved (the
shape, number, and intensity of areas of inhomogeneity),
but there are likely others present here and in other real
data sets. For example, methods may have different sensi-
tivity depending on the areal size and/or location of
spatial differences. In these cases, the sensitivity of each
method may differ depending on location of a particular
hot or cold spot, even when size, shape and intensity of
the hot/cold spot are comparable (e.g. differing "edge
effects" across methods).
Each of these methods would be expected to have certain
strengths and weaknesses. The M-statistic has been imple-
mented both in case-control studies [5], and in surveil-
lance settings [18] where there is a large amount of
historical data to use as a baseline for the null distribution
of distances. Simulations suggest that it has the potential
to be sensitive to situations such as multiple hot spots,
where other statistics (such as the scan statistic) may lose
power [3,4], but these same studies show that the M-sta-
tistic will typically underperform other statistics when
there is a single hot spot to detect.
Provided there is some historical record, or sufficiently
large control population from which to resample, the M-
statistic can handle small sample sizes adequately. This is
important in a surveillance setting, and is an advantage
over rate-based statistics that may have insufficient data in
the small sample case to draw proper inferences. In envi-
ronmental settings these situations may arise in small,
neighborhood-sized population studies.
Breast cancer 20 year latency (GAM) Figure 2
Breast cancer 20 year latency (GAM). Breast cancer 20 
year latency, GAM smoothed rate map. Solid lines delineate 
areas where the point-wise GAM deviance statistic is less 
than 0.05.
Breast cancer 20 year latency (scan) Figure 3
Breast cancer 20 year latency (scan). Breast cancer 20 
year latency, scan statistic most likely cluster. Estimated rela-
tive risk for the indicated cluster is 0.823.Environmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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However, as currently implemented the M-statistic does
not adjust for covariates, but instead is used on raw spatial
data only. The origins of the M-statistic lie in public health
surveillance where spatial confounders are implicitly
accounted for in the immediate historical record. As noted
above, the M-statistic does not locate hot spots, but rather
detects a difference between the two populations under
comparison. Because these differences are quantified via
the interpoint distance distribution and not the geo-
graphic locations of cases and controls themselves, results
do not have a direct interpretation as do the "most likely
cluster" of the scan statistic or the local odds ratios of the
GAM.
GAM smoothing is a robust data-based approach that can
be run with standard software. The ability to map disease
outcomes while adjusting for covariates in a way familiar
to epidemiologists is a particular strength. It is semi-para-
metric, assuming a linear model in the covariates with an
additive spatial effect. Ignoring covariates and considering
the data on a purely spatial basis there are essentially no
statistical assumptions required, although the choice of
window size may affect the sensitivity of the smoothing
approach. The GAM approach provides global statistics to
test the map for overall deviation from flatness as well as
a pointwise test to locate areas of significantly elevated
and decreased disease risk. Sufficient sample size for sta-
ble rates is also important, and results for small sample
sizes are difficult to interpret meaningfully.
The scan statistic will certainly excel [3,4] when there is a
single hot spot present and that hot spot is roughly circu-
lar in shape. The model assumption of a Bernoulli distri-
bution inside and outside a circular region can be
suboptimal if either the hot/cold spot is not circular, or if
there is more than one spot present. There has been
additional work on the scan statistic focusing on examin-
ing or improving robustness to the shape of the hotspot
[19-21].
The scan statistic is especially appealing because of its
immediate identification of the most likely cluster. Public
availability of the implementation via the SaTScan soft-
ware has increased its popularity and visibility. Perhaps
most importantly, the method's exceptional power to
detect single hot spots deserves consideration in situa-
tions where a single hot spot scenario seems plausible, or
even possible. As a rate-based approach, the scan statistic
is also limited to sample sizes that provide stable rate
estimates.
Aggregated data can be handled using a Poisson model,
similar in spirit to the Bernoulli model used for case-con-
trol data. The currently available software can adjust for
covariates in the Poisson case, and adjustments for
Breast cancer 15 year latency (GAM) Figure 4
Breast cancer 15 year latency (GAM). Breast cancer 15 
year latency.
Breast cancer 15 year latency (scan) Figure 5
Breast cancer 15 year latency (scan). Breast cancer 15 
year latency. RR = 4.629.Environmental Health: A Global Access Science Source 2005, 4:19 http://www.ehjournal.net/content/4/1/19
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categorical variables in the Bernoulli model are allowed in
the most recent release of the SaTScan software.
Multiple hot/cold spots would seem to be problematic
when using the scan statistic, since it uses a likelihood
function from a model based on a single hot or cold spot
only. Placing restrictions on the underlying probability
model clearly results in higher power when the model is
correctly specified, but the presence of multiple clusters
would imply that the scan statistic has misspecified the
model. Thus we should expect that in some of these
situations the scan statistic may suffer loss of power. The
GAM and M-statistic would be expected to be sensitive to
a wider variety of multiple cluster arrangements, but this
flexibility is inherent in the global nature of these test sta-
tistics in contrast to the essentially local nature of the scan
statistic.
The published results cited above indicate that for the
benchmark simulated data considered, the scan statistic is
quite robust to some multiple cluster arrangements. We
note that these comparisons are dependent on the simu-
lated data used for the purposes of the power study. Mul-
tiple hot/cold spots may be common occurrences in real
data sets, and a more thorough effort to generate realistic
simulations for these data is a direction for future
research.
Likewise, there is no reason to assume that areas of
increased risk will be any particular shape, especially as
neither underlying population nor possible exposures are
similarly constrained. Several recent papers have contin-
ued investigation of the scan statistic and its performance
when dealing with non-circular hot spots (as well as
extensions of the methodology to improve robustness in
these situations); see for example [17]. As with the issue of
multiple hot spots, more work may be needed to simulate
such data in a realistic manner. We again emphasize the
importance of studies that consider real data in addition
to synthetic data, and the potential to learn from both
types of data as spatial methods continue to develop and
improve.
Conclusion
With the variety of approaches to the problem of examin-
ing spatial patterns of disease, it is not surprising that
some methods are more effective than others for detecting
certain patterns. A better understanding of the relative
strengths and weaknesses of the various methods is essen-
tial to appropriate choices of methodology. Studies of
spatial distribution of disease will also benefit from the
information available from a variety of statistical
Breast cancer no latency (GAM) Figure 6
Breast cancer no latency (GAM). Breast cancer no 
latency.
Breast cancer no latency (scan) Figure 7
Breast cancer no latency (scan). Breast cancer no 
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methods, and careful consideration of the complemen-
tary nature of this information should assist in the inter-
pretation of results of studies with a spatial component.
To this point, much of the work in gaining this under-
standing has come from analyzing synthetic data, where
the underlying model can be controlled and various fea-
tures superimposed in order to perform a careful study of
these strengths and weaknesses. However, some character-
istics of real data sets may be hard to simulate with syn-
thetic data, or may not be readily apparent in advance of
analysis and further study, and results based on simulated
data are at least partially dependent on the particular sim-
ulations themselves.
The comparative analyses by different methods of real
data sets point to directions for further research of the
properties of each of the statistics used in this paper. We
suggest a further research program designed around alter-
nately examining real and simulated data sets for these
kinds of differences, in order to develop the practical
application of statistical methods to epidemiological data
with a spatial component.
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